Supplementary Figure S2 from Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights

作者：Allison L. Brodsky, Amma Asare, Bryan Fellman, Kristin Anderson, Jun Yao, Sanghoon Lee, Hai Tran, Xun Xu, Jinsong Liu, Joseph Celestino, Richard A. Hajek, Margaret B. Morgan, Mohammad Mohammad, Pamela Soliman, Aaron Shafer, Anil K. Sood, Diane Bodurka, Nicole D. Fleming, Michaela Onstad Grinsfelder, Ljiljana Milojevic, Amir A. Jazaeri, Gordon B. Mills, Robert L. Coleman, Shannon N. Westin · 年份：2026 · DOI：10.1158/1078-0432.31910962 · 研究领域：PARP inhibition in cancer therapy、Endometrial and Cervical Cancer Treatments、Ovarian cancer diagnosis and treatment

<p>RPPA analysis on-treatment</p>